Background

Mr. Dana G. Mead, Jr., has been an Investment Partner and Partner at Kleiner Perkins Caufield & Byers, since May 2005. Mr. Mead joined Kleiner, Perkins, Caufield & Byers in May 2005. He is a part of the life sciences team and focuses on pandemic, and biodefense investments. He leverages experience gained from his venture-funded, start-up management roles, and board participation to support entrepreneurs and innovators. He served as the President at Vascular Intervention ... at Guidant Corp. (alternate name Guidant, LLC) since March 11, 2003 and served as the Vice President of Corporate Relations and Policy until March 11, 2003. He was responsible for investor relations, corporate communications, corporate marketing, and public policy initiative. He joined the firm in 1992. Previously, he served as the President of Japan and Asia/Pacific at Guidant Corp. from March 2000 to March 2002, the Vice President and General Manager of Stents for Vascular Intervention from 1998 to February 2000, the Vice President and General Manager of Cardiac and Vascular Surgery from 1997 to 1998, the Vice President of Global Marketing of Cardiac and Vascular Surgery through 1997, and a Director of Marketing and Director of Sales at Cardiac and Vascular Surgery from 1994 to 1996. He served in various sales and marketing management roles at Johnson & Johnson Inc. and Allergan Inc. He served as an Executive Officer of Allergan Inc. and Johnson & Johnson. He has been a Director of Intersect ENT Inc. since June 2007. He serves as a Director of Corventis Inc., Apnicure, Awarepoint Corporation, Sinexus, Inc., Pulmonx, Inc., Spiracur Inc., Navigenics, Inc., Synvascular, Invuity, Inc., Spinal Modulation, Teladoc, Inc., Voyage Medical, Inc., Sonitus, Amigo Therapy, and Inspire Medical Systems. He serves as a Director of California Healthcare Institute and Lucille Packard Children's Hospital at Stanford University and was Chairman of the Lafayette College West Coast Advisory Council. He served as a Director of Aesthera Corporation since February 22, 2006, OtisMed Corporation, Cardica Inc., and eValve, Inc. He served as a Member of Advisory Board at RWI Ventures. He was a Director of the Cardiovascular Research Foundation. His career has focused on identifying new medical technologies, developing new markets and therapies, and building world-class management teams for the last 30 years. He has worked with physician thought leaders around the world representing 12 different medical specialties. Mr. Mead holds an M.B.A. from the University of Southern California and received a B.A. from Lafayette College.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.